All lobbying filings

MICHAEL BEST STRATEGIES LLC

MICHAEL BEST STRATEGIES LLC filed a Q3 report for GENEDX on October 20, 2026, reporting $30,000 in lobbying income.

Lobbying for GENEDX · Biotechnology company.

All filings by MICHAEL BEST STRATEGIES LLC · Everything GENEDX has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 20, 2026

Income

$30,000

What the client paid this registrant for the period.

Client based in

Connecticut

Official filing document

Government bodies contacted 1

Defense, Dept of (DOD)

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 3

Defense

TRICARE decision to not pay for genome/exnome sequencing testing for DoD personnel and family members.

Health Issues

TRICARE decision to not pay for genome/exnome sequencing testing for DoD personnel and family members.

Insurance

TRICARE decision to not pay for genome/exnome sequencing testing for DoD personnel and family members.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.